Acto Company which was proved itself in disinfectants production against hospital infections, has also started to sell molecular biology and genetics products and to establish genetic diagnosis centers.
The mission of Acto GmbH is manufacturing, sales-marketing, and distribution of disinfectants, antiseptics, cleaners and care products, cosmetic products, MRSA and VRE effective wound care products, industrial cleaning, food cleaning and disinfectant group, biotechnological and genetic products for hospital infections. The products are produced and controlled according to the quality standard systems such as GMP, 93/42/EC, EN ISO 13485: 2003, DIN EN ISO 9001:2000 and CE.
The new product group; Genetics, Molecular Biology products and Genetics Diagnostic Centers As a result of the developments in the field of genetics in recent years, many hereditary diseases can be detected in the post pregnancy period, prenatal and pre-implantation periods. The “Genetic Diagnosis Center” was established in 2006 in order to provide and to apply to these developments at the same time as the world.
We should say that; the company which works with expert genetic engineers and biologists; has been in talks with many distinguished hospitals in order to establish its Genetic Laboratories. The company does not only produce kits for the diagnosis of genetic diseases; but it has also developed viral, bacterial and fungal detection kits and Salmonella detection kit which is extremely important for food safety. The Genetic Products group is consisted of DNA isolation kits, RNA isolation kits, PCR Enzymes, PCR master mixtures, DNA Markers, the tampons used in PCR, bacterial detection kits, virus detection kits, fungus detection kits and parasite detection kits.
Acto Company which has established the scientific and technological infrastructure in order to establish its Genetic Diagnosis Center as well as the production of kits; therefore it has entered to a new market. As a result of early detection and diagnosis which will be provided in Genetic Diagnosis Center; the diseases will be prevented in advance. The company also aims to provide the possibility of identifying the gender of baby from mother’s blood using the new genetic detection kit in 2013 at the company’s own centers.
At the center, it will be supported the scientific studies and projects that will apply chromosome, FISH and DNA analysis which are required in order to detect genetic diseases.
The Genetic Diagnosis Center which is going to be established will provide the following services;
Clinical Genetics
Genetic Counseling
Cytogenetic
Molecular Cytogenetic (FISH)
Molecular Genetics
Cancer Genetics
Pharmacogenetics
Preimplantation Genetic Diagnosis (PGD)